PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEMOPHILIA RECEIVING FITUSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC TARGETING ANTITHROMBIN FOR THE TREATMENT OF HEMOPHILIA
A.N.L. Prezotti,
K.J. Pasi,
C. Négrier,
M.V. Ragni,
P. Georgiev,
T. Lissitchkov,
K. Salim,
B. Mei,
S. Andersson
Affiliations
A.N.L. Prezotti
Centro de Hemoterapia e Hematologia do Espírito Santo (HEMOES), Vitória, ES, Brazil
K.J. Pasi
Royal London Hospital Haemophilia Centre, Barts and the London School of Medicine and Dentistry, London, United Kingdom
C. Négrier
Unité d’Hémostase Clinique, Centre Régional de Traitement de l’Hémophilie, Hôpital Louis Pradel, Lyon, France
M.V. Ragni
Department of Medicine and Hemophilia Center of Western Pennsylvania, University of Pittsburgh, Pittsburgh, United States
P. Georgiev
University Multiprofile Hospital for Active Treatment Sveti Georgi and Medical University Plovdiv, Plovdiv, Bulgaria
T. Lissitchkov
Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria
